Amgen To Present At The UBS Global Life Sciences Conference

         Amgen To Present At The UBS Global Life Sciences Conference

PR Newswire

THOUSAND OAKS, Calif., May 16, 2013

THOUSAND OAKS, Calif., May 16, 2013 /PRNewswire/ --Amgen (NASDAQ:AMGN) will
participate in the UBS Global Life Sciences Conference on Tuesday, May 21,
2013, at the Sheraton New York Times Square in New York City, beginning at
10:00 a.m. Eastern Daylight Time. Joseph P. Miletich, M.D., Ph.D., senior vice
president of Research and Development at Amgen, will present at the
conference. Live audio of the presentation can be accessed from the Events
Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for 90 days following the
event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping people around the world in the fight
against serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)



SOURCE Amgen

Website: http://www.amgen.com
 
Press spacebar to pause and continue. Press esc to stop.